Tamiva SR: Dosages and Ingredients | Full Prescribing Info

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contents

Tamsulosin hydrochloride.

Description

Each SR tablet contains: Tamsulosin Hydrochloride 0.4 mg.
Excipients/Inactive Ingredients: Polyethylene Oxide, Macrogol 8000, Pregelatinized Starch, Hydroxypropyl Methylcellulose, Yellow Iron Oxide, Magnesium Stearate, Butylated Hydroxytoluene.

Indications/Uses

Lower Urinary Tract Symptoms (LUTS), Symptomatic benign prostatic hyperplasia (BPH).

Dosage/Direction for Use

0.4 mg once daily.

Contraindications

Hypersensitivity to Tamsulosin Hydrochloride and any component of this product, Orthostatic hypotension, Congestive heart failure.

Special Precautions

Large residual volume and/or severely diminished urinary flow (monitor for obstructive uropathy), exclude prostate cancer.

Adverse Reactions

Heart disorders: Palpitations.
Gastrointestinal disorders: Constipation, diarrhea, nausea, vomiting, dry mouth.
General disorders: Asthenia.
Nervous system disorders: Dizziness, headache, syncope.
Reproductive system disorders: Ejaculation disorders, priapism.
Respiratory, thoracic and mediastinal disorders: Rhinitis, epistaxis.
Skin and subcutaneous tissue disorders: Rash, itching, urticaria, angioedema, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, photosensitivity reactions.
Vascular disorders: Orthostatic hypotension.
Eye disorders: Blurred vision, visual disturbances.
During cataract and glaucoma surgery, a condition of constricted pupils, known as Intraoperative Floppy Iris Syndrome (IFIS) has been reported during post-marketing studies.
As with the use of other alpha blockers, drowsiness may occur.

View ADR Reporting Link

Drug Interactions

Concomitant use with Cimetidine increases plasma levels of Tamsulosin, while Furosemide decreases Tamsulosin levels, but since plasma levels are still within the normal range, no dose adjustment is necessary.
Concomitant use with other alpha-adrenoreceptor antagonists may result in hypotensive effects.

MIMS Class

Drugs for Bladder & Prostate Disorders

ATC Classification

G04CA02 - tamsulosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Tamiva SR tab 0.4 mg

Packing/Price

3 × 10's

Tamiva SR

tamsulosin

Manufacturer:

Interbat